̽»¨¾«Ñ¡

In the second week of September, Hans-Gustaf Ljunggren, NextGenNK Director, together with KI President Annika Wernerson, met up with the Vinnova General Director Darja Isaksson. Among things discussed were advances within the ATMP field including NextGenNK’s efforts in developing novel NK cell-based immunotherapies. On a larger scale, the research and innovation development in Europe were discussed.